Cargando…
Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy
AIM: The aim of the present study was to compare the treatment outcome in oral cancer cases treated with neoadjuvant chemotherapy (NACT) and upfront surgery in localized advance disease. MATERIALS AND METHODS: A randomized, prospective study was conducted in 20 cases. Patients were divided into two...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485539/ https://www.ncbi.nlm.nih.gov/pubmed/37694015 http://dx.doi.org/10.4103/jpbs.jpbs_196_23 |
_version_ | 1785102810302382080 |
---|---|
author | Sarma, Mridul Kumar Missong, Ajit K. Sharma, Moitrayee Debnath, Asim Mahanta, Neelakshi Choudhury, Mrinmoy M. |
author_facet | Sarma, Mridul Kumar Missong, Ajit K. Sharma, Moitrayee Debnath, Asim Mahanta, Neelakshi Choudhury, Mrinmoy M. |
author_sort | Sarma, Mridul Kumar |
collection | PubMed |
description | AIM: The aim of the present study was to compare the treatment outcome in oral cancer cases treated with neoadjuvant chemotherapy (NACT) and upfront surgery in localized advance disease. MATERIALS AND METHODS: A randomized, prospective study was conducted in 20 cases. Patients were divided into two groups. Group A was taken up for upfront surgery and group B was taken up for surgery after two to three cycles of NACT based on patients’ response, performance, and compliance. RESULTS: Neither group showed statistically significant differences in clinical characteristics. In the present study, satisfactory outcomes were seen in nine patients belonging to NACT group and eight patients of non-NACT group had satisfactory outcomes after surgery, which were found to be statistically significant (P = 0.001). CONCLUSION: NACT may be considered as a treatment option for oral squamous cell carcinoma patients, particularly those with locally advanced tumors. Further prospective studies are needed to validate these findings in patients. |
format | Online Article Text |
id | pubmed-10485539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-104855392023-09-09 Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy Sarma, Mridul Kumar Missong, Ajit K. Sharma, Moitrayee Debnath, Asim Mahanta, Neelakshi Choudhury, Mrinmoy M. J Pharm Bioallied Sci Original Article AIM: The aim of the present study was to compare the treatment outcome in oral cancer cases treated with neoadjuvant chemotherapy (NACT) and upfront surgery in localized advance disease. MATERIALS AND METHODS: A randomized, prospective study was conducted in 20 cases. Patients were divided into two groups. Group A was taken up for upfront surgery and group B was taken up for surgery after two to three cycles of NACT based on patients’ response, performance, and compliance. RESULTS: Neither group showed statistically significant differences in clinical characteristics. In the present study, satisfactory outcomes were seen in nine patients belonging to NACT group and eight patients of non-NACT group had satisfactory outcomes after surgery, which were found to be statistically significant (P = 0.001). CONCLUSION: NACT may be considered as a treatment option for oral squamous cell carcinoma patients, particularly those with locally advanced tumors. Further prospective studies are needed to validate these findings in patients. Wolters Kluwer - Medknow 2023-07 2023-07-11 /pmc/articles/PMC10485539/ /pubmed/37694015 http://dx.doi.org/10.4103/jpbs.jpbs_196_23 Text en Copyright: © 2023 Journal of Pharmacy and Bioallied Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Sarma, Mridul Kumar Missong, Ajit K. Sharma, Moitrayee Debnath, Asim Mahanta, Neelakshi Choudhury, Mrinmoy M. Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy |
title | Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy |
title_full | Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy |
title_fullStr | Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy |
title_full_unstemmed | Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy |
title_short | Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy |
title_sort | comparison of post-operative complications in oral cancer treated with and without neoadjuvant chemotherapy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485539/ https://www.ncbi.nlm.nih.gov/pubmed/37694015 http://dx.doi.org/10.4103/jpbs.jpbs_196_23 |
work_keys_str_mv | AT sarmamridulkumar comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy AT missongajitk comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy AT sharmamoitrayee comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy AT debnathasim comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy AT mahantaneelakshi comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy AT choudhurymrinmoym comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy |